New Animal Drugs For Use In Animal Feeds; Monensin and Bacitracin Methylene Disalicylate
other · Food and Drug Administration · Rule · Published 1998-10-02 · Effective 1998-10-02 · 63 FR 52969
Document
Document number
98-26425
Federal Register citation
63 FR 52969
CFR reference
21 CFR 558
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1998-10-02
Effective date
1998-10-02
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA provides for using approved single ingredient monensin and bacitracin methylene disalicylate (BMD) Type A medicated articles to make an additional approved combination for a monensin/BMD Type C medicated turkey feed.